Riskpilot← Back to searchSign inGet full accessAB Medicab AE
ABDissolvedOrg 5568379399Other education n.e.c. · NACE 8559Est. 20111 employees
Revenue 2023
SEK 0
EBITDA margin
—
-7% vs 2022
Equity ratio
69.0%
Financial strength
Net profit 2023
SEK -3K
-1740% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -23K | -7% |
| Net profit | SEK -3K | -1740% |
| Total assets | SEK 165K | -57% |
| Equity | SEK 114K | -64% |
| Employees | 1 | — |
Legal name
AB Medicab AE
Org number
5568379399
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
12 januari 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget ska bedriva medicinsk och psykiatrisk mottagningsverksamhet, psykoanalys och lärare-, handledareuppdrag, kurser och föreläsningar inom psykiatri och psykoterapi samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 907 | 596 | 274 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 787 | 527 | 161 | −21 | −23 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 787 | 527 | 161 | −21 | −23 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | 788 | 544 | 119 | −0 | −3 |
| Tax | −173 | −120 | −26 | — | — |
| Net profit | 615 | 424 | 93 | −0 | −3 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1 106 | 899 | 702 | 381 | 165 |
| Equity | 693 | 602 | 500 | 312 | 114 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 397 | 297 | 161 | 50 | 51 |
| Total debt | 397 | 297 | 161 | 50 | 51 |
EBITDA margin
-2279400.0%
This company
15.8%
Market median
-14426682% vs market
20192023
Equity ratio
69.0%
This company
38.2%
Market median
+81% vs market
20192023
Return on equity
-2.2%
This company
18.4%
Market median
-112% vs market
20192023
Net profit margin
-250300.0%
This company
8.1%
Market median
-3090223% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
EA Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Medicab AE also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eli Atanasiadu Högberg | Chief Executive Officer | 0 companies |
| Lena Birgitta Killgren Jonsson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Board of Directors | 0 companies |
| Claes Torbjörn Högberg | Deputy Board Member | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Erik Torbjörn Andreas Högberg | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Deputy Board Member | 0 companies |